Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.6400
+0.0310 (5.09%)
At close: Aug 25, 2026, 4:00 PM EDT
0.6433
+0.0033 (0.52%)
After-hours: Aug 25, 2026, 7:58 PM EDT
Outlook Therapeutics Employees
Outlook Therapeutics had 17 employees as of September 30, 2025. The number of employees decreased by 6 or -26.09% compared to the previous year.
Employees
17
Change (1Y)
-6
Growth (1Y)
-26.09%
Revenue / Employee
n/a
Profits / Employee
-$3,595,486
Market Cap
155.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 17 | -6 | -26.09% |
| Sep 30, 2024 | 23 | -1 | -4.17% |
| Sep 30, 2023 | 24 | 7 | 41.18% |
| Sep 30, 2022 | 17 | 8 | 88.89% |
| Sep 30, 2021 | 9 | 1 | 12.50% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsOTLK News
- 8 days ago - Outlook Therapeutics announces common stock, warrants offering - TheFly
- 8 days ago - Outlook Therapeutics $100M Spot Secondary re-offered at 99c - TheFly
- 8 days ago - Outlook Therapeutics 55.6M share Spot Secondary priced at 99c - TheFly
- 9 days ago - Outlook Therapeutics reports Q3 EPS (15c), consensus (8c) - TheFly
- 11 days ago - Outlook Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - Outlook Therapeutics Earnings release: Q3 2026 - Filings
- 11 days ago - Outlook Therapeutics Quarterly report: Q3 2026 - Filings
- 11 days ago - Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™ - GlobeNewsWire